A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

Clinical trial NCT05092841 · COMPLETED

Trial details

NCT number: NCT05092841
Sponsor: Tasly GeneNet Pharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Charcot-Marie-Tooth Type 1A

Start date: 2021-09-28
Primary completion: 2024-03-18
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.